MiRNA regulatory mechanism in tumor initiation and progression

Journal of Central South University (Medical Sciences)

Volumn 38, Issue 12, 2013, Pages 1282-1283

  Zhao, Ran ^a   Zhou, Ming ^a   Wang, Heran ^a   Xiong, Wei ^a   Li, Xiaoling ^a   Li, Guiyuan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ceRNA; miRNA; Regulation network; Target gene; Transcription factor; Tumor

Indexed keywords

MICRORNA;

APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HUMAN; NEOPLASM; ONCOGENE;

APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; NEOPLASMS; ONCOGENES;

EID: 84894160773     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2013.12.013     Document Type: Review

References (50)

1. Chen CH, Guo M, Hay BA. Identifying microRNA regulators of cell death in Drosophila[J]. Methods Mol Biol, 2006,342(1): 229-240.
2. Lynn FC. Meta-regulation: microRNA regulation of glucose and lipid metabolism[J]. Trends Endocrinol Metab, 2009,20(9): 452-459.
3. Xiao C, Rajewsky K. MicroRNA control in the immune system: basic principles[J]. Cell, 2009,136(l1): 26-36.
4. Lin HR, Ganem D. Viral microRNA target allows insight into the role of translation in governing microRNA target accessibility[J]. Proc Natl Acad Sci USA, 2011,108(13): 5148-5153.
5. Chang S, Wang RH, Akagi K, et al. Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155[J]. Nat Med, 2011, 17(10): 1275-1282.
6. Soifer HS, Rossi JJ, Saetrom P. MicroRNAs in disease and potential therapeutic applications[J]. Mol Ther, 2007,15(12): 2070-2079. (Pubitemid 350148921)
7. LI Guiyuan. Foundation of modern oncology[M]. Beijing: Science Press, 2011:323-329.
8. Barh D, Malhotra R, Ravi B, et al MicroRNA let-7: an emerging nextgeneration cancer therapeutic[J]. Curr Oncol, 2010,17(1): 70-80.
9. Yamazaki H, Chijiwa T, Inoue Y, et al. Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 genep[J]. Exp Ther Med, 2012,3(5): 793-796.
10. Dai L, Wang W, Zhang S, et aL Vector-based miR-15a/16-l plasmid inhibits colon cancer growth in vivo[J], Cell Biol Int, 2012,36(8): 765-770.
11. Musumeci M, Coppola V, Addario A, et al. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer[J], Oncogene, 2011,30(41): 4231-4242.
12. Pan X, Wang ZX, Wang R. MicroRNA-21 : A novel therapeutic target in human cancer[J]. Cancer Biol Ther, 2010,10(12): 1224-1232.
13. Ibrahim SA, Yip GW, Stock C, et al. Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism[J]. Int J Cancer, 2012,131(6): E884-E896.
14. Mardente S, Mari E, Consorti F, et al. HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells[J]. Oncol Rep, 2012, 28(6): 2285-2289.
15. Turner MJ, Slack FJ. Transcriptional control of microRNA expression in C. elegans: promoting better understanding[J]. RNA Biol, 2009, 6(1): 49-53.
16. Kai ZS, Finnegan EF, Huang S, et al. Multiple cis-elements and transacting factors regulate dynamic spatio-temporal transcription of let-7 in Caenorhabditis elegans[J]. Dev Biol, 2013,374(1): 223-233.
17. Liu H, Zhou M, Luo X, et al. Transcriptional regulation of BRD7 expression by Spl and c-Myc[J]. BMC Mol Biol,2008,9(1): 111.
18. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression[J]. Nat Rev Cancer, 2012,12(9): 613-626.
19. Schmeier S, MacPherson CR, Essack M, et al. Deciphering the transcriptional circuitry of microRNA genes expressed during human monocyticdifferentiation[J]. BMC Genomics, 2009,10(1): 595.
20. Zeller KI, Zhao X, Lee CW, et al. Global mapping of c-Myc binding sites and target gene networks in human B cells [J]. Proc Natl Acad Sci USA, 2006,103(47): 17834-17839. (Pubitemid 44852246)
21. Yin Q, Wang X, McBride J, et al. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element[J]. J Biol Chem, 2008,283(5): 2654-2662.
22. Gatto G, Rossi A, Rossi D, et al. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway[J], Nucleic Acids Res, 2008,36(20): 6608-6619.
23. Chang TC, Yu D, Lee YS, et al. Widespread microRNA repression by Myc contributes to tumorigenesis[J]. Nat Genet, 2008,40(1): 43-50.
24. Yu J, Cai X, He J, et al. Microarray-based analysis of gene regulation by transcription factors and microRNAs in glioma[J], Neurol Sci, 2013, 34(8): 1283-1289.
25. Lin KY, Zhang XJ, Feng DD, et al. miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies[J]. J Biol Chem, 2011, 286(44): 38253-38263.
26. Liu Z, Liu H, Desai S, et al. miR-125b functions as a key mediator for the snail-induced stem cell propagation and chemoresistance[J]. J Biol Chem, 2013,288(6): 4334-4345.
27. Zhou M, Liu Z, Zhao Y, et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bd-2 antagonist killer 1 (Bak1) expression[J]. J Biol Chem, 2010, 285(28): 21496-21507.
28. Schramedei K, Morbt N, Pfeifer G, et aL MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4[J]. Oncogene, 2011, 30(26): 2975-2985.
29. Liu ZL, Wang H, Liu J, et al. MicroRNA-21 (miR-2l) expression promotes growth, metastasis, and chemo- or radioresistance in nonsmall cell lung cancer cells by targeting PTEN[J]. Mol Cell Biochem, 2013,372(1/2): 35-45.
30. Chen G, Zhu W, Shi D, et al. MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2[J], Oncol Rep, 2010,23(4): 997-1003.
31. Shen J, Wan R, Hu G, et al. miR-15b and miR-16 induce the apoptosis of rat activated pancreatic stellate cells by targeting Bcl-2 in vitro[J]. Pancreatology, 2012,12(2): 91-99.
32. Liu L, Chen L, Xu Y, et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells[J]. Biochem Biophys Res Commun, 2010,400(2): 236-240.
33. Jaskiewicz L, Filipowicz W. Role of Dicer in posttranscriptional RNA silencing[J]. Curr Top Microbiol Immunol, 2008,320(1): 77-97.
34. Zhang X, Zeng Y. The terminal loop region controls microRNA processing by Drosha and Dicer[J]. Nucleic Acids Res, 2010, 38(21): 7689-7697.
35. Feng Y, Zhang X, Graves P, et al A comprehensive analysis of precursor microRNA cleavage by human Dicer[J]. RNA, 2012, 18(11): 20832092.
36. Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma[J], Cancer Cell, 2011, 19(2): 232243.
37. Michael MZ, O'Connor SM, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia[J], Mol Cancer Res, 2003,1(12): 882-891. (Pubitemid 37288707)
38. Martello G, Rosato A, Ferrari F, et al. A microRNA targeting dicer for metastasis control[J]. Cell, 2010,141(7): 1195-1207.
39. Khoshnaw SM, Rakha EA, Abdel-Fatah TM, et al. Loss of Dicer expression is associated with breast cancer progression and recurrence[J], Breast Cancer Res Treat, 2012,135(2): 403-413.
40. Guo X, Liao Q, Chen P, et al. The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma[J]. J Cancer Res Clin Oncol, 2012,138(1): 49-56.
41. Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta stone of a hidden RNA language?[J], Cell, 2011,146(3): 353-358.
42. Tay Y, Kats L, Salmena L, et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs[J]. Cell, 2011,147(2): 344-357.
43. Rarreth FA, Tay Y, Perna D, et al. In vivo identification of tumorsuppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma[J]. Cell, 2011,147(2): 382-395.
44. Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology [J]. Nature, 2010,465(7301): 1033-1038.
45. Fang L, Du WW, Yang X, et al. Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity[J]. FASEB J, 2013,27(3): 907-919.
46. Jeyapalan Z, Deng Z, Shatseva T, et al. Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis[J]. Nucleic Acids Res, 2011, 39(8): 3026-3041.
47. Rutnam ZJ, Yang BB. The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions[J]. J Cell Sci, 2012,12S(Pt 8): 2075-2085.
48. Tsang J, Zhu J, van Oudenaarden A. MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals[ J]. Mol Cell, 2007,26(5): 753-767. (Pubitemid 46856248)
49. Iliopoulos D, Hirsch HA, Struhl R. An epigenetic switch involving NF-kappaB, lin28, let-7 microRNA, and IL6 links inflammation to cell transformation[J]. Cell, 2009,139(4): 693-706.
50. .WU Hui, FU Yongming, XIAO Jun, et al. Expression and purification of the N-terminal of RSHV encoded G-protein coupled receptor containing the sulfotyrosines[J]. Journal of Natural Science of Hunan Normal University, 2011,34(6): 62-67.